Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oral peanut immunotherapy How much is too much? How much is enough?
Katharina Bluemchen, Thomas Eiwegger
Allergy (2018) Vol. 74, Iss. 2, pp. 220-222
Open Access | Times Cited: 14

Showing 14 citing articles:

Allergen Immunotherapy in Children User’s Guide
Montserrat Álvaro‐Lozano, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S25, pp. 1-101
Open Access | Times Cited: 273
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study
R. Sharon Chinthrajah, Natasha Purington, Sandra Andorf, et al.
The Lancet (2019) Vol. 394, Iss. 10207, pp. 1437-1449
Open Access | Times Cited: 266
Mechanisms of allergen-specific immunotherapy and allergen tolerance
Umut Can Küçüksezer, Cevdet Özdemir, Lacin Cevhertas, et al.
Allergology International (2020) Vol. 69, Iss. 4, pp. 549-560
Open Access | Times Cited: 139
Recent developments and highlights in food allergy
Thomas Eiwegger, Lisa Hung, Kristen Ericka San Diego, et al.
Allergy (2019) Vol. 74, Iss. 12, pp. 2355-2367
Open Access | Times Cited: 98
Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care
Heimo Breiteneder, Zuzana Diamant, Thomas Eiwegger, et al.
Allergy (2019) Vol. 74, Iss. 12, pp. 2293-2311
Open Access | Times Cited: 96
Scientific Opinion on development needs for the allergenicity and protein safety assessment of food and feed products derived from biotechnology
Ewen Mullins, Jean‐Louis Bresson, Tamás Dalmay, et al.
EFSA Journal (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 50
Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial
Tonje Reier‐Nilsen, Karin C. Lødrup Carlsen, Merethe Melbye Michelsen, et al.
Pediatric Allergy and Immunology (2019) Vol. 30, Iss. 6, pp. 638-645
Closed Access | Times Cited: 39
Oral Immunotherapy
Krista Todoric, Sarah Merrill
Medical Clinics of North America (2024) Vol. 108, Iss. 4, pp. 719-731
Closed Access | Times Cited: 3
Reduction in Allergenicity and Induction of Oral Tolerance of Glycated Tropomyosin from Crab
Xinyu Han, Tianliang Bai, Yang Huang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 2027-2027
Open Access | Times Cited: 9
Oral Immunotherapy
Krista Todoric, Sarah Merrill
Primary Care Clinics in Office Practice (2023) Vol. 50, Iss. 2, pp. 269-281
Closed Access | Times Cited: 3
Immunothérapie orale aux aliments (ITO) pour une pratique raisonnée
É. Bidat, G. Benoist
Revue française d'allergologie (2020) Vol. 60, Iss. 6-7, pp. 559-565
Open Access | Times Cited: 5
High-dose oral immunotherapy in children with anaphylaxis to peanut
Tonje Reier‐Nilsen
(2019)
Closed Access
Schwere Nahrungsmittelallergien – ist eine Toleranzinduktion möglich?
Jochen Meister, Katja Nemat
Kinder- und Jugendmedizin (2020) Vol. 20, Iss. 05, pp. 298-304
Closed Access
Session internationale : vers la prévention et le traitement personnalisé de l’allergie alimentaire
J. Corriger, L. Pellicer-Garcia, A. Valeille, et al.
Revue française d'allergologie (2021) Vol. 61, Iss. 5, pp. 328-336
Open Access
Page 1

Scroll to top